Shoshana Armoni
Overview
Explore the profile of Shoshana Armoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gileles-Hillel A, Soesman L, Miari S, Breuer O, Tsabari R, Elyashar-Earon H, et al.
Pediatr Pulmonol
. 2022 Aug;
57(11):2774-2780.
PMID: 35999051
Background: Consistently abnormal glucose levels on oral glucose tolerance test (OGTT) are the most effective screening tool for cystic fibrosis-related diabetes (CFRD). However, some cystic fibrosis (CF) patients demonstrate abnormal...
2.
Israeli T, Eisenstadt I, Shoseyov D, Armoni S, Gileles-Hillel A, Cremisi G, et al.
Pediatr Pulmonol
. 2022 Mar;
57(6):1552-1554.
PMID: 35322603
We report physiotherapy management of two patients with severe cystic fibrosis (CF) lung disease and upper limb deep vein thrombosis (DVT). These patients were admitted due to a pulmonary exacerbation....
3.
Abu-Fraiha Y, Elyashar-Earon H, Shoseyov D, Cohen-Cymberknoh M, Armoni S, Kerem E, et al.
J Pediatr Gastroenterol Nutr
. 2018 Aug;
68(1):110-115.
PMID: 30095576
Context: In 2012, The North American Cystic Fibrosis Foundation (NACFF) published new guidelines for the treatment of vitamin D deficiency in individuals with cystic fibrosis (CF). Objective: The objectives of...
4.
Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, et al.
J Cyst Fibros
. 2016 May;
15(6):776-782.
PMID: 27143583
Objectives: To determine eradication success rate of newly acquired PA and to identify characteristics associated with eradication failure. Methods: In an observational study, data from patients with newly acquired PA...
5.
Pugatsch T, Shoseyov D, Cohen-Cymberknoh M, Hayut B, Armoni S, Griese M, et al.
Pediatr Pulmonol
. 2015 Nov;
51(2):143-6.
PMID: 26583331
Background: Clinical trials are all based on the assumption that patients are adherent to the study protocol. Many reports indicate that general adherence of patients with CF to their daily...
6.
Tsabari R, Elyashar H, Cymberknowh M, Breuer O, Armoni S, Livnat G, et al.
J Cyst Fibros
. 2015 Nov;
15(3):e25-7.
PMID: 26547591
Objective: To investigate the effect of treatment with ivacaftor on insulin secretion in patients with cystic fibrosis (CF) (ΔF508\S549R) having CFRD/impaired insulin secretion. Methods: A standard OGTT was performed before...
7.
Breuer O, Cohen-Cymberknoh M, Armoni S, Kerem E, Shoseyov D
Ann Allergy Asthma Immunol
. 2014 Jun;
113(2):229-30.
PMID: 24934107
No abstract available.
8.
Werlin S, Benuri-Silbiger I, Kerem E, Adler S, Goldin E, Zimmerman J, et al.
J Pediatr Gastroenterol Nutr
. 2010 Jun;
51(3):304-8.
PMID: 20512061
Objectives: Treatment with pancreatic enzymes fails to completely correct malabsorption and gastrointestinal symptoms in patients with cystic fibrosis (CF). The aim of the present study was to examine the small...
9.
Klein M, Cohen-Cymberknoh M, Armoni S, Shoseyov D, Chisin R, Orevi M, et al.
Chest
. 2009 Aug;
136(5):1220-1228.
PMID: 19696124
Background: Airway inflammation plays a critical role in the progression of cystic fibrosis (CF) lung disease, and in the destruction of airways and lung parenchyma. Current methods to assess CF...
10.
Cohen-Cymberknoh M, Blau H, Shoseyov D, Mei-Zahav M, Efrati O, Armoni S, et al.
J Cyst Fibros
. 2009 May;
8(4):253-7.
PMID: 19447081
Background: Allergic bronchopulmonary aspergillosis (ABPA) in patients with CF is associated with frequent exacerbations and deterioration of lung function. Oral corticosteroids are standard therapy for ABPA and are associated with...